Abellanosa, Christine .

HRN: 25-93-58  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/05/2024
CEFUROXIME 500MG (TAB)
11/05/2024
11/11/2024
PO
1 Tab
BID
UTI; RMLE
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary TractBloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: